Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
« Previous Article | Table of Contents | Next Article »
Arteriosclerosis, Thrombosis, and Vascular Biology. 1994;14:1193-1201

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Michelson, A. D.
Right arrow Articles by Barnard, M. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Michelson, A. D.
Right arrow Articles by Barnard, M. R.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH

Arteriosclerosis and Thrombosis, Vol 14, 1193-1201, Copyright © 1994 by American Heart Association

ARTICLES

Platelet activation results in a redistribution of glycoprotein IV (CD36)

AD Michelson, JD Wencel-Drake, AS Kestin and MR Barnard
Department of Pediatrics, University of Massachusetts Medical School, Worcester 01655.

To investigate the possibility that thrombin and/or other platelet activators change the platelet surface expression of glycoprotein IV (GPIV, CD36), we used a panel of five GPIV-specific monoclonal antibodies (OKM5, 5F1, FA6-152, 8A6, and F13) directed against different epitopes. All these antibodies bound to resting platelets in a concentration-dependent and saturable manner, as determined by flow cytometry of washed platelets. Thrombin (1 U/mL) induced an approximately twofold increase in the platelet surface binding of each of these monoclonal antibodies. Immunofluorescence microscopy demonstrated an internal pool of GPIV that, after thrombin stimulation, redistributed to the platelet surface. In a whole-blood flow-cytometric assay, alpha-thrombin and the thromboxane A2 analogue U46619 each resulted in an approximately twofold increase in the platelet surface binding of OKM5, whereas ADP had a more modest effect, and collagen and epinephrine had little effect. The activation-induced up-regulation of the platelet OKM5 epitope occurred in vivo as demonstrated by flow cytometric analysis of whole blood emerging from a standardized skin puncture site. In summary, both in vitro and in vivo platelet activation results in increased platelet surface expression of GPIV, as a result of a redistribution of GPIV from an internal pool.


This article has been cited by other articles:


Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
A. Kereveur, J. Callebert, M. Humbert, P. Herve, G. Simonneau, J.-M. Launay, and L. Drouet
High Plasma Serotonin Levels in Primary Pulmonary Hypertension : Effect of Long-Term Epoprostenol (Prostacyclin) Therapy
Arterioscler Thromb Vasc Biol, October 1, 2000; 20(10): 2233 - 2239.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
T. Nakagawa, S. Nozaki, M. Nishida, J. M. Yakub, Y. Tomiyama, A. Nakata, K. Matsumoto, T. Funahashi, K. Kameda-Takemura, Y. Kurata, et al.
Oxidized LDL Increases and Interferon-{gamma} Decreases Expression of CD36 in Human Monocyte–Derived Macrophages
Arterioscler Thromb Vasc Biol, August 1, 1998; 18(8): 1350 - 1357.
[Abstract] [Full Text] [PDF]


ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search
Copyright © 1994 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited.